Valuation: CTT Pharmaceutical Holdings, Inc.

Market Cap 3.33M 2.97M 2.72M 2.47M 4.66M 315M 4.79M 32.63M 13.05M 167M 12.51M 12.24M 526M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 3.34M 2.97M 2.72M 2.48M 4.67M 315M 4.79M 32.67M 13.06M 167M 12.52M 12.25M 527M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.4%
Yield 2024 *
-
Yield 2025 -
1 day-5.42%
1 week-5.26%
Current month-5.42%
1 month+1.45%
3 months-14.15%
6 months-29.37%
Current year-7.16%
1 week 0.04
Extreme 0.035
0.06
1 month 0.04
Extreme 0.035
0.06
Current year 0.04
Extreme 0.035
0.1
1 year 0.04
Extreme 0.035
0.1
3 years 0.01
Extreme 0.01
0.15
5 years 0
Extreme 0.003
0.15
10 years 0
Extreme 0.003
2.17
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
10/6/26 A BuyCompany 3,700 0.0063%
9/28/26 A BuyCompany 3,400 0.0058%
9/22/26 A BuyCompany 10,100 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-5.42%-5.26%-7.00%+65.33% 3.33M
+3.80%+8.10%+63.78%+77.70% 69.4B
-2.31%-1.31%+8.03%+72.50% 57.24B
-1.35%+2.05%+23.66%+98.37% 57.62B
+0.41%-3.70%+26.06%+34.32% 43.65B
+2.51%+4.22%+20.49%+110.71% 44.03B
-11.04%-6.63%+199.38%+701.67% 38.08B
+7.50%+13.58%+29.07%+64.46% 36.31B
-4.06%-11.78%+84.79%+72.38% 32.61B
-2.18%+7.06%+36.06%-4.95% 25.47B
Average -1.22%+1.99%+48.43%+129.25% 40.44B
Weighted average by Cap. -0.39%+3.12%+50.99%+130.75%

Financials

2024 2025
Net sales - -
Net income -250K -223K -204K -186K -350K -23.65M -360K -2.45M -980K -12.52M -939K -919K -39.52M -156K -139K -127K -116K -218K -14.73M -224K -1.53M -610K -7.8M -585K -573K -24.62M
Net Debt 16.82K 14.99K 13.71K 12.48K 23.53K 1.59M 24.17K 165K 65.85K 842K 63.13K 61.77K 2.66M 3.46K 3.08K 2.82K 2.56K 4.83K 327K 4.96K 33.83K 13.53K 173K 12.97K 12.69K 546K
Projected Income Statement - Annual - CTT Pharmaceutical Holdings, Inc.
Logo CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-
Date Price Change Volume
04/11/26 $0.0558 -5.42% 398,900
03/11/26 $0.0590 0.00% 22,071
30/10/26 $0.0590 +0.17% 38,300
28/10/26 $0.0589 +11.98% 7,000
  1. Stock Market
  2. Stocks
  3. CTTH Stock